This same effect of curcumin was further validated in BC tumors using a PDX model (proven to be HRP by the RECAP assay [24]), showing reduction in RAD51 IRIF numbers in a dose-dependent manner (Figure 2A,B). The gene discussed is RAD51; the disease is breast cancer.